Subodh Verma

Also affiliated with University of Toronto

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 32 papers. Top paper: “Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes”.

Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes

JAMA(2020)10.1001/jama.2020.1906

N/A

6.7DataRank · unranked

539 citations

Subodh Verma, Kieran F. Docherty, Silvio E. Inzucchi, Inder S. Anand, Jan Bělohlávek +34 more

Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial

Nature Medicine(2023)10.1038/s41591-023-02526-x

N/A

5.5DataRank · unranked

193 citations

Dalane W. Kitzman, Melanie J. Davies, Søren Rasmussen, Eric Barros, Javed Butler +23 more

Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials

The Lancet(2024)10.1016/s0140-6736(24)00469-0

N/A

5.3DataRank · unranked

335 citations

Sanjiv J. Shah, Mark C. Petrie, Barry A. Borlaug, Steen Z. Abildstrøm, Melanie J. Davies +27 more

Initial Decline (Dip) in Estimated Glomerular Filtration Rate After Initiation of Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: Insights From DAPA-HF

Circulation(2022)10.1161/circulationaha.121.058910

N/A

4.7DataRank · unranked

131 citations

Kieran F. Docherty, Hiddo J.L. Heerspink, Rudolf A. de Boer, Kevin Damman, Silvio E. Inzucchi +16 more

Semaglutide in Patients With Obesity and Heart Failure Across Mildly Reduced or Preserved Ejection Fraction

Journal of the American College of Cardiology(2023)10.1016/j.jacc.2023.09.811

N/A

2.7DataRank · unranked

82 citations

Steen Z. Abildstrøm, Barry A. Borlaug, Melanie J. Davies, Dalane W. Kitzman, Mark C. Petrie +19 more

Dapagliflozin and the Incidence of Type 2 Diabetes in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis From DAPA-HF

Diabetes Care(2020)10.2337/dc20-1675

N/A

2.7DataRank · unranked

76 citations

Kieran F. Docherty, Lars Køber, Mikhail Kosiborod, Felipe A. Martínez, Piotr Ponikowski +16 more

Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure With Reduced Ejection Fraction: An Analysis of DAPA-HF

Circulation(2021)10.1161/circulationaha.121.053659

N/A

2.5DataRank · unranked

60 citations

Piotr Ponikowski, Kieran F. Docherty, Samvel B. Gasparyan, Michael Böhm, Chern‐En Chiang +16 more

Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial

Circulation(2023)10.1161/circulationaha.123.067505

N/A

2.5DataRank · unranked

96 citations

Subodh Verma, Barry A. Borlaug, Javed Butler, Melanie J. Davies, Thomas Jensen +10 more

Semaglutide and NYHA Functional Class in Obesity-Related Heart Failure With Preserved Ejection Fraction

Journal of the American College of Cardiology(2024)10.1016/j.jacc.2024.04.038

N/A

2.0DataRank · unranked

48 citations

Mark C. Petrie, Barry A. Borlaug, Javed Butler, Melanie J. Davies, Dalane W. Kitzman +9 more

DNA damage repair and cardiovascular diseases

Canadian Journal of Cardiology(2010)10.1016/s0828-282x(10)71055-2

N/A

1.9DataRank · unranked

42 citations

Krishna K. Singh, Bobby Yanagawa, Hwee Teoh, Subodh Verma, Praphulla C. Shukla

Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: an analysis of DAPA‐HF

European Journal of Heart Failure(2020)10.1002/ejhf.2083

N/A

1.7DataRank · unranked

48 citations

Kieran F. Docherty, Olof Bengtsson, Rudolf A. de Boer, Akshay S. Desai, Jarosław Dróżdż +19 more

Atrial Fibrillation and Semaglutide Effects in Obesity-Related Heart Failure With Preserved Ejection Fraction

Journal of the American College of Cardiology(2024)10.1016/j.jacc.2024.08.023

N/A

1.6DataRank · unranked

37 citations

Javed Butler, Barry A. Borlaug, Melanie J. Davies, Dalane W. Kitzman, Mark C. Petrie +8 more

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

New England Journal of Medicine(2019)10.1056/nejmoa1911303

N/A

1.3DataRank · unranked

5622 citations

Scott D. Solomon, Silvio E. Inzucchi, Lars Køber, Mikhail N. Kosiborod, Felipe A. Martinez +43 more

Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial

The Lancet Diabetes & Endocrinology(2022)10.1016/s2213-8587(22)00308-4

N/A

1.2DataRank · unranked

41 citations

Brian Claggett, Muthiah Vaduganathan, Akshay S. Desai, Pardeep S. Jhund, Rudolf A. de Boer +14 more

Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial

Circulation(2022)10.1161/circulationaha.122.062769

N/A

1.1DataRank · unranked

35 citations

C. David Mazer, Pankaj Puar, Hwee Teoh, Chao‐Hung Wang, Tamique Mason +29 more

Decline in Estimated Glomerular Filtration Rate After Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

JAMA Cardiology(2023)10.1001/jamacardio.2023.4664

N/A

1.0DataRank · unranked

38 citations

Brian Claggett, Muthiah Vaduganathan, Akshay S. Desai, Pardeep S. Jhund, Orly Vardeny +17 more

Efficacy of Dapagliflozin in Black Versus White Patients With Heart Failure and Reduced Ejection Fraction

JACC Heart Failure(2021)10.1016/j.jchf.2021.08.006

N/A

0.900DataRank · unranked

49 citations

Modele O. Ogunniyi, Inder S. Anand, Akshay S. Desai, Mirta Díez, Jonathan G. Howlett +17 more

Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized for Heart Failure

Circulation(2025)10.1161/circulationaha.125.076575

N/A

0.794DataRank · unranked

37 citations

Siddharth M. Patel, Paul M. Haller, Abby L. Cange, Michael G. Palazzolo, Andrea Bellavia +23 more

Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial

The Lancet Diabetes & Endocrinology(2025)10.1016/s2213-8587(24)00362-0

N/A

0.700DataRank · unranked

31 citations

Deepak L. Bhatt, Michael Szarek, Christopher P. Cannon, Lawrence A. Leiter, Silvio E. Inzucchi +17 more

Semaglutide in obesity-related heart failure with preserved ejection fraction and type 2 diabetes across baseline HbA1c levels (STEP-HFpEF DM): a prespecified analysis of heart failure and metabolic outcomes from a randomised, placebo-controlled trial

The Lancet Diabetes & Endocrinology(2025)10.1016/s2213-8587(24)00304-8

N/A

0.613DataRank · unranked

20 citations

Peter van der Meer, Subodh Verma, Shachi Patel, Khaja Chinnakondepalli, Barry A Borlaug +11 more

Semaglutide and Exercise Function in Obesity-Related HFpEF

JACC Heart Failure(2025)10.1016/j.jchf.2025.102660

N/A

0.328DataRank · unranked

5 citations

Dalane W. Kitzman, Shachi Patel, Khaja Chinnakondepalli, Javed Butler, Melanie J. Davies +9 more

Methemoglobin as a marker of acute anemic stress in cardiac surgery

iScience(2023)10.1016/j.isci.2023.107429

N/A

0.263DataRank · unranked

4 citations

Gregory M. T. Hare, Nadine Shehata, Robert S. Kramer, Hosam Fawzy, Robert A. Baker +17 more

Effects of SGLT2 Inhibitors on Kidney and Cardiovascular Function

Annual Review of Physiology(2020)10.1146/annurev-physiol-031620-095920

N/A

0DataRank · unranked

494 citations

Subodh Verma, Volker Vallon

Optimal cardiometabolic health and risk of heart failure in type 2 diabetes: an analysis from the Look AHEAD trial

European Journal of Heart Failure(2022)10.1002/ejhf.2723

N/A

0DataRank · unranked

14 citations

Muhammad Shahzeb Khan, Matthew W. Segar, Judy Bahnson, Katelyn R Garcia, Jeanne M. Clark +9 more

Intracranial Hemorrhage During Dual Antiplatelet Therapy

Journal of the American College of Cardiology(2021)10.1016/j.jacc.2021.07.048

N/A

0DataRank · unranked

63 citations

Deepak L. Bhatt, James T. Rutka, S. Claiborne Johnston, C. David Mazer, Subodh Verma +1 more

Fasting status and metabolic health in relation to plasma branched chain amino acid concentrations in women

Metabolism(2020)10.1016/j.metabol.2020.154391

N/A

0DataRank · unranked

11 citations

Samia Mora, Subodh Verma, Filio Billia, Julie E. Buring, Patrick R. Lawler +1 more

Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events

JACC Heart Failure(2023)10.1016/j.jchf.2023.05.026

N/A

0DataRank · unranked

46 citations

Deepak L. Bhatt, Michael Szarek, Christopher P. Cannon, Lawrence A. Leiter, Darren K. McGuire +17 more

Restrictive versus liberal transfusion in patients with diabetes undergoing cardiac surgery: An o pen‐label, randomized, blinded outcome evaluation trial

Diabetes Obesity and Metabolism(2021)10.1111/dom.14591

N/A

0DataRank · unranked

7 citations

Nadine Shehata, Paula Carmona, Daniel Bolliger, Raymond Hu, François Martin Carrier +18 more

Geographical Variation in Patient Characteristics and Outcomes in Heart Failure with Mildly Reduced and Preserved Ejection Fraction

European Journal of Heart Failure(2024)10.1002/ejhf.3352

N/A

0DataRank · unranked

12 citations

Toru Kondo, Pardeep S. Jhund, Marco A. Alcocer‐Gamba, C. Jan Willem Borleffs, Chern‐En Chiang +17 more

Colchicine for cardiovascular and limb risk reduction in Medicare beneficiaries with peripheral artery disease: emulation of target trials

European Heart Journal Open(2024)10.1093/ehjopen/oeae062

N/A

0DataRank · unranked

12 citations

James J. Fitzgibbon, Eric A. Secemsky, Deepak L. Bhatt, Mohammed Al‐Omran, Subodh Verma +4 more

Commentary: More arteries, better outcomes: A Latin American perspective on multiarterial grafting in coronary artery bypass grafting

Journal of Thoracic and Cardiovascular Surgery(2025)10.1016/j.jtcvs.2025.07.021

N/A

0DataRank · unranked

0 citations

Shubh Patel, Mario Gaudino, John D. Puskas, Subodh Verma

Efficacy and safety of dapagliflozin in patients hospitalized with COVID-19 with and without type 2 diabetes: a prespecified analysis of the DARE-19 randomized trial

Cardiovascular Diabetology(2025)10.1186/s12933-025-02875-6

N/A

0DataRank · unranked

0 citations

Remo H.M. Furtado, Russell Esterline, Jan Oscarsson, Samvel B. Gasparyan, Gary G. Koch +18 more